期刊
BRITISH JOURNAL OF PSYCHIATRY
卷 221, 期 2, 页码 488-493出版社
CAMBRIDGE UNIV PRESS
DOI: 10.1192/bjp.2022.34
关键词
Antidepressants; developmental disorders; intellectual disability; information technologies; polypharmacy
类别
Prescribing of psychotropic medications for people with intellectual disability has changed, with antidepressants becoming the most widely prescribed. It is important to understand whether this change is evidence-based and to analyze the benefits or concerns associated with it.
The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据